A study examining once-weekly semaglutide treatment found that weight reduction was accompanied by significant decreases in serum albumin, vitamin B12, and zinc levels
In the Phase 2 obesity trial published in NEJM in 2023, retatrutide at the 12 mg weekly dose produced a mean placebo-adjusted body weight reduction of 22.1 percentage points (22.1% (24.2% arm) mean absolute reduction on the retatrutide arm) at 48 weeks (Jastreboff et al., NEJM, 2023)
Bottom Line Injection site reactions are one of the more common experiences when starting a GLP-1, and for most people, they stay mild and resolve on their own within a few days
Teaser pricing: some telehealth platforms advertise low introductory prices that increase after the first month or as your dose goes up
My whole life is being in the gym, working out, running, training, HIIT training, dancing, every single thing you can think of
Mboumi said